Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells
β Scribed by Maehata, Yojiro; Ozawa, Shigeyuki; Kobayashi, Kyo; Kato, Yasumasa; Yoshino, Fumihiko; Miyamoto, Chihiro; Izukuri, Kazuhito; Kubota, Eiro; Hata, Ryu-Ichiro; Lee, Masaichi-Chang-Il
- Book ID
- 120393674
- Publisher
- Informa plc
- Year
- 2010
- Tongue
- English
- Weight
- 652 KB
- Volume
- 44
- Category
- Article
- ISSN
- 1071-5762
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Cisplatin is a chemotherapeutic agent that is widely used to treat cancers such as head and neck squamous cell carcinoma (HNSCC). Previously, we have reported that cisplatin induced an early caspaseβdependent apoptosis (8 hr) in a HNSCC cell, HN4. In this study, we examined a late caspa
Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (HNSCCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this